INTC · Investment summary · as of 3 August 2026
Priced for an operating path the record does not support
Business type: Cyclical · cyclical or commodity-sensitive
The operating path required by today's price is not achievable on the evidence.
At $90.99, INTC requires a 36% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at -0%.
The disagreement with the market is terminal-margin normalization on modest growth (COHR shape): loss-making Foundry stops bleeding and Products' 31.8% shows through.
The value rests on an exit multiple of 2.9x, a terminal operating margin of 25% and a 11.1% cost of capital. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.
The strongest argument against this view: Intel Foundry never wins a material external customer: external revenue $293m in Q2 2026 ($467m H1) against a $2,089m quarterly Foundry operating loss; mention-frequency shows Intel de-emphasising 18A/14A 60-84% over nine quarters.
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | The disagreement with the market is terminal-margin normalization on modest growth (COHR shape): loss-making Foundry stops bleeding and Products' 31.8% shows through. |
| What do we forecast? | Revenue growth of -0% demonstrated; a terminal operating margin of 25%; an exit multiple of 2.9x. |
| What does Street forecast? | Not determined — no consensus estimates are joined to this record |
| Where do we differ? | On terminal margin, the difference between what the price requires and what the business has demonstrated is -50.1 percentage points. |
| What is it worth? | Not determined — Consensus FY27E EPS 2.04 (revised +25%/90d) puts forward P/E at 44.6x. |
| Why now? | Date not announced — no dated event that would resolve the disagreement is on file |
| Date or window | Event | Thesis confirmed if | Thesis weakened or refuted if |
|---|---|---|---|
| 22 October 2026 | Next results (date estimated, not issuer-confirmed) | Revenue and margin in line with, or above, the house path | A miss that moves the full-year path below the guided floor |
Dates marked as estimated are drawn from the company’s own reporting cadence, not from an announcement.
Intel Foundry never wins a material external customer: external revenue $293m in Q2 2026 ($467m H1) against a $2,089m quarterly Foundry operating loss; mention-frequency shows Intel de-emphasising 18A/14A 60-84% over nine quarters. The ~$105bn net PP&E then supports only internal demand and the consolidated margin stays in the 0-12% band. not a going-concern case: liquid assets $29.7bn, H1 FCF +$1.9bn, state shareholder raises the solvency floor (Principle 5).
Estimated probability 35%, against the 16% level at which the position would be resized. It sits above that level, so this case could not be carried at full size.
Falsifiable and fundamental — not one of them is a price condition.
Trim/exit at EV/NTM-Sales >= 10.6x (own all-time high) absent IC1/IC2 having fired: forward E[R] is negative at every window of the name's own multiple history at that point.
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Met | Is the business worth owning under its declared economic type? |
| Valuation | Not met | Is the operating path required by today's price achievable? |
| Liquidity | Not determined | Can the intended position be built and exited in the right vehicle? Not established on the evidence on file. |
| Downside | Met | Intel Foundry never wins a material external customer: external revenue $293m in Q2 2026 ($467m H1) against a $2,089m quarterly Foundry operating loss; mention-frequency shows Intel de-emphasising 18A/14A 60-84% over nine quarters. |
| Momentum | Not determined | Does price action support or complicate entry timing? Not established on the evidence on file. |
| Catalyst | Not determined | Is there a dated event that resolves the disagreement? Not established on the evidence on file. |
| Consensus | Not determined | Is the house-versus-Street disagreement identified and quantified? Not established on the evidence on file. |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The gap between what today's price requires and what the business has demonstrated is -50.1 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is whether a position could be built and exited at the intended size. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $68.24, which forces an immediate review.